CSIMarket
 
Green Planet Bioengineering Co Ltd   (GPLB)
Other Ticker:  
 
 
Price: $0.6000 $0.54 883.607%
Day's High: $0.6 Week Perf: 883.61 %
Day's Low: $ 0.60 30 Day Perf: -76 %
Volume (M): 0 52 Wk High: $ 1.10
Volume (M$): $ 0 52 Wk Avg: $0.70
Open: $0.60 52 Wk Low: $0.06



 Market Capitalization (Millions $) 12
 Shares Outstanding (Millions) 20
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Green Planet Bioengineering Co Ltd
Green Planet Bioengineering Co Ltd is a company that specializes in bioengineering and focuses on developing sustainable and eco-friendly solutions. They aim to leverage their expertise in biotechnology to create innovative products that contribute to a greener planet. Their portfolio includes a range of environmentally friendly products such as biofuels, organic fertilizers, and biodegradable materials. Green Planet Bioengineering Co Ltd is committed to research and development and works towards promoting global sustainability by reducing carbon emissions and minimizing the use of harmful chemicals.


   Company Address: 20807 Biscayne Blvd. Aventura 33180 FL
   Company Phone Number: 279-2900   Stock Exchange / Ticker: GPLB
   GPLB is expected to report next financial results on March 29, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Green Planet Bioengineering Co Ltd

Green Planet Bioengineering Co Ltd shines in Q3 2023, outperforming rivals

As a biotechnology and pharmaceuticals industry reporter for the , I have been closely monitoring the third-quarter performance of various companies in the sector. One company that has drawn my attention is Green Planet Bioengineering Co Ltd (GPLB), which recently released its financial results for the period of July to September 2023.
The most striking aspect of GPLB's financial report is the operating shortfall of $-0.007752 million. This indicates that the company has not generated any specified revenue during this period. While this may cause concern for some investors, it is important to note that GPLB is in the process of evolving its business model.

Green Planet Bioengineering Co Ltd

Green Planet Bioengineering Co Ltd Faces Challenges in Q2 2023, Shareholders Concerned About Operating Deficit and Revenue Generation



Green Planet Bioengineering Co Ltd, a prominent player in the Biotechnology & Pharmaceuticals sector, has faced challenges during the April to June 2023 earnings season. Shareholders express concern over the company's operating deficit, which has worsened compared to the same period in 2022. Additionally, analysts are questioning when Green Planet will start reporting revenue. With the management seeking new strategies to ensure growth, all eyes are on their upcoming financial earnings report, scheduled for November 13, 2023.
Operating Deficit:
During the earnings season of April to June 2023, Green Planet Bioengineering Co Ltd recorded an operating deficit of $-0.008528 million. This marked a deterioration from the second quarter of 2022 when the deficit was $-0.005449 million. The widening operating deficit raises alarms as shareholders seek answers regarding the company's ability to generate revenue and sustain profitability.

Green Planet Bioengineering Co Ltd

Green Planet Bioengineering Co Ltd Makes Strides Towards Profitability in First Quarter of 2023

The Green Planet Bioengineering Co Ltd (GPLB) is a company that investors should keep a close eye on, as it has the potential to become a real game-changer. Despite reporting an operating loss of $-0.01784 million in the first quarter of 2023, the fact that this is an improvement on the previous year's loss of $-0.013658 million is a step in the right direction.
Although the company reported a net loss of $-0.018 million, investors should not be alarmed by this. The loss has only increased slightly from the previous year, with the fiscal span ending March 31, 2022, showing figures of $-0.014 million. This is still a positive sign, as the company is showing signs of stability even in these early stages.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com